title: A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function.
abstract: In cancer cells, failure of chemotherapy is often caused by the ATP-binding cassette subfamily B member 1 (ABCB1), and few drugs have been successfully developed to overcome ABCB1-mediated multi-drug resistance (MDR). To suppress ABCB1 activity, we previously designed and synthesized a new series of derivatives based on 20(S)-protopanoxadiol (PPD). In the present study, we investigated the role of PPD derivatives in the function of ABC transporters. Non-toxic concentrations of the PPD derivative PPD12 sensitized ABCB1-overexpressing cells to their anti-cancer substrates better than either the parental PPD or inactive PPD11. PPD12 increased intracellular accumulation of adriamycin and rhodamine123 in resistant cancer cells. Although PPD12 did not suppress the expression of ABCB1 mRNA or protein, it stimulated the activity of ABCB1 ATPase. Because PPD12 is a competitive inhibitor, it was predicted to bind to the large hydrophobic cavity of homology-modeled human ABCB1. PPD12 also enhanced the efficacy of adriamycin against ABCB1-overexpressing KB/VCR xenografts in nude mice. In conclusion, PPD12 enhances the efficacy of substrate drugs in ABCB1-overexpressing cancer cells. These findings suggest that a combination therapy consisting of PPD12 with conventional chemotherapeutic agents may be an effective treatment for ABCB1-mediated MDR cancer patients.
authors.affiliation: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, P. R. China.|Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai 200011, P. R. China.
authors.forename: Gang
authors.initials: G
authors.lastname: Chen
authors.affiliation: Shanghai Research Center for Modernization of Traditional Chinese Medicine, Shanghai Institute of Material Medica, Chinese Academy of Sciences, Shanghai 201203, P. R. China.
authors.forename: Junhua
authors.initials: J
authors.lastname: Liu
authors.affiliation: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, P. R. China.|Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai 200011, P. R. China.
authors.forename: Wantao
authors.initials: W
authors.lastname: Chen
authors.affiliation: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, P. R. China.|Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai 200011, P. R. China.
authors.forename: Qin
authors.initials: Q
authors.lastname: Xu
authors.affiliation: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, P. R. China.|Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai 200011, P. R. China.
authors.forename: Meng
authors.initials: M
authors.lastname: Xiao
authors.affiliation: Shanghai Research Center for Modernization of Traditional Chinese Medicine, Shanghai Institute of Material Medica, Chinese Academy of Sciences, Shanghai 201203, P. R. China.
authors.forename: Lihong
authors.initials: L
authors.lastname: Hu
authors.affiliation: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, P. R. China.|Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, USA.
authors.forename: Li
authors.initials: L
authors.lastname: Mao
authors.affiliation: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, P. R. China.|Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai 200011, P. R. China.
authors.forename: Xu
authors.initials: X
authors.lastname: Wang
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B / Q000037:antagonists & inhibitors; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D004357:Drug Synergism; D057809:HEK293 Cells; D018922:HL-60 Cells; D006801:Humans; D061986:MCF-7 Cells; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009369:Neoplasms / Q000188:drug therapy*; D012235:Rhodamines / Q000494:pharmacology; D012502:Sapogenins / Q000737:chemistry / Q000494:pharmacology*; D023041:Xenograft Model Antitumor Assays
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D000970:Antineoplastic Agents; D012235:Rhodamines; D012502:Sapogenins; D004317:Doxorubicin; C062916:protopanaxadiol
keywords: ABCB1; apoptosis; chemotherapy; multi-drug resistance; panax ginseng
references.citation: Chirality. 2015 Feb;27(2):170-6
references.pmid: 25422175
references.citation: Biochem Pharmacol. 2012 Apr 15;83(8):1084-103
references.pmid: 22248732
references.citation: Expert Opin Drug Metab Toxicol. 2014 Oct;10 (10 ):1337-54
references.pmid: 25162314
references.citation: J Can Res Updates. 2013 Oct 31;2(4):265-282
references.pmid: 24634705
references.citation: Nat Struct Mol Biol. 2015 Jan;22(1):57-64
references.pmid: 25486304
references.citation: Toxicol In Vitro. 2014 Dec;28(8):1498-506
references.pmid: 24975508
references.citation: Bioorg Med Chem Lett. 2014 Dec 1;24(23):5409-12
references.pmid: 25453798
references.citation: Fitoterapia. 2015 Jan;100:208-20
references.pmid: 25449425
references.citation: Phytomedicine. 2014 Jul-Aug;21(8-9):1110-9
references.pmid: 24856768
references.citation: Pharmacol Ther. 2015 May;149:1-123
references.pmid: 25435018
references.citation: Bioorg Med Chem. 2013 Jul 15;21(14):4279-87
references.pmid: 23683834
references.citation: J Vet Intern Med. 2015 Jan;29(1):1-6
references.pmid: 25619511
references.citation: Clin Cancer Res. 2008 Sep 1;14(17):5594-601
references.pmid: 18765553
references.citation: Chin Med. 2011 Jul 22;6(1):27
references.pmid: 21777476
references.citation: Oncol Lett. 2014 Apr;7(4):1265-1269
references.pmid: 24944704
references.citation: F1000Prime Rep. 2015 Feb 03;7:14
references.pmid: 25750732
references.citation: Pharmgenomics Pers Med. 2014 Feb 05;7:53-64
references.pmid: 24523596
references.citation: PLoS One. 2012;7(4):e35768
references.pmid: 22530069
references.citation: Nutrients. 2015 Jan 23;7(2):799-814
references.pmid: 25625815
references.citation: Mol Pharmacol. 2013 Nov;84(5):655-69
references.pmid: 24021215
references.citation: Nat Rev Drug Discov. 2015 Jan;14(1):29-44
references.pmid: 25475361
references.citation: PLoS One. 2014 Jun 12;9(6):e98717
references.pmid: 24922060
references.citation: Biomed Pharmacother. 2015 Mar;70:140-5
references.pmid: 25776492
references.citation: Biochem Pharmacol. 2013 Feb 15;85(4):514-24
references.pmid: 23261525
references.citation: Basic Clin Pharmacol Toxicol. 2013 Jan;112(1):25-33
references.pmid: 22759348
references.citation: Curr Drug Targets. 2011 May;12(5):621-30
references.pmid: 21039338
references.citation: J Pharmacol Sci. 2014;125(3):242-54
references.pmid: 24989947
references.citation: Adv Drug Deliv Rev. 2015 Jun 23;86:17-26
references.pmid: 25769815
references.citation: Evid Based Complement Alternat Med. 2015;2015:736431
references.pmid: 25632290
references.citation: Exp Oncol. 2014 Sep;36(3):144-56
references.pmid: 25265346
references.citation: Phytomedicine. 2015 Feb 15;22(2):301-7
references.pmid: 25765837
references.citation: Cancers (Basel). 2014 Sep 29;6(4):1925-52
references.pmid: 25268163
references.citation: Int J Biochem Mol Biol. 2012;3(1):1-27
references.pmid: 22509477
references.citation: Nat Commun. 2014 Nov 07;5:5419
references.pmid: 25377891
references.citation: J Adv Res. 2015 Jan;6(1):45-62
references.pmid: 25685543
references.citation: Planta Med. 2009 Aug;75(10):1124-8
references.pmid: 19291609
references.citation: Sci Rep. 2015 Feb 26;5:8598
references.pmid: 25716943
references.citation: Evid Based Complement Alternat Med. 2013;2013:957078
references.pmid: 23533531
references.citation: Cancer Biol Ther. 2006 Jan;5(1):39-47
references.pmid: 16319528
references.citation: Mol Clin Oncol. 2014 Nov;2(6):1043-1046
references.pmid: 25279195
references.citation: Oncotarget. 2015 Jun 20;6(17 ):15494-509
references.pmid: 25915534